help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism , doi:10.1210/jc.2006-2338
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chang, H.-W.
Right arrow Articles by Wu, K.-D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chang, H.-W.
Right arrow Articles by Wu, K.-D.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Adrenal Gland Cancer
Hazardous Substances DB
*CALCIUM COMPOUNDS
*CALCIUM, ELEMENTAL
Related Collections
Right arrow Adrenal and Hypertension
Right arrow Endocrine Oncology
The Journal of Clinical Endocrinology & Metabolism Vol. 92, No. 5 1863-1870
Copyright © 2007 by The Endocrine Society

Down-Regulation of D2 Dopamine Receptor and Increased Protein Kinase Cµ Phosphorylation in Aldosterone-Producing Adenoma Play Roles in Aldosterone Overproduction

Hong-Wei Chang, Tzong-Shinn Chu, Hong-Yu Huang, Shih-Chieh Chueh, Vin-Cent Wu, Yung-Ming Chen, Bor-Shen Hsieh and Kwan-Dun Wu

Nephrology Division (H.-W.C., T.-S.C., H.-Y.H., V.-C.W., Y.-M.C., B.-S.H., K.-D.W.), Department of Internal Medicine, and Department of Urology (S.-C.C.), National Taiwan University Hospital, Taipei, Taiwan 100

Address all correspondence and requests for reprints to: Kwan-Dun Wu, M.D., Ph.D., Room 1419, Clinical Research Building, Department of Internal Medicine, National Taiwan University Hospital, 7 Chung-Sun South Road, Taipei, Taiwan 100. E-mail: kdw{at}ntumc.org.

Context: The mechanism associated with the overproduction of aldosterone by aldosterone-producing adenomas (APA) is unknown.

Objective: The objective of the study was to explore the role of the D2 dopamine receptor (D2R) on aldosterone synthesis and secretion and clarify the clinical importance of this role on aldosterone overproduction in APA.

Results: D2R expression in APA was examined in 24 patients and was much less than that in the nontumorous adrenal cortex. D2R mRNA levels in APA were inversely correlated with CYP11B2 mRNA levels and the patient’s plasma aldosterone concentration. Angiotensin II (AII)-stimulated aldosterone secretion and CYP11B2 mRNA expression in human adrenocarcinoma cells (H295R) was attenuated by the D2 agonist, bromocriptine (BMC). BMC selectively attenuated AII-induced protein kinase C (PKC)-µ phosphorylation and its translocation to the cell membrane. PKCµ-specific short-hairpin RNA significantly decreased AII-induced CYP11B2 mRNA expression and aldosterone secretion. BMC also attenuated the AII-induced increase in cytoplasmic calcium, partially through an inhibition of cytoplasmic inositol 1,4,5 triphosphate production. Despite similar total PKCµ levels in APA and the nontumorous adrenal cortex, expression of phosphorylated PKCµ in APA was much higher.

Conclusion: This is the first study to demonstrate that the D2R modulated aldosterone secretion and synthesis through a specific attenuation of PKCµ activity, as well as the intracellular calcium level. Down-regulation of the D2R in APA, in turn, increased PKCµ activity and led to overproduction of aldosterone in affected patients. The D2R may thus serve as a potential treatment target for primary aldosteronism.




This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
H.-W. Chang, V.-C. Wu, C.-Y. Huang, H.-Y. Huang, Y.-M. Chen, T.-S. Chu, K.-D. Wu, and B.-S. Hsieh
D4 dopamine receptor enhances angiotensin II-stimulated aldosterone secretion through PKC-{varepsilon} and calcium signaling
Am J Physiol Endocrinol Metab, March 1, 2008; 294(3): E622 - E629.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Li, L. A. Chen, C. M. Townsend Jr., and B. M. Evers
PKD1, PKD2, and Their Substrate Kidins220 Regulate Neurotensin Secretion in the BON Human Endocrine Cell Line
J. Biol. Chem., February 1, 2008; 283(5): 2614 - 2621.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
V.C. Wu, S.C. Chueh, H.W. Chang, W.C. Lin, K.L. Liu, H.Y. Li, Y.H. Lin, K.D. Wu, and B.S. Hsieh
Bilateral aldosterone-producing adenomas: differentiation from bilateral adrenal hyperplasia
QJM, January 1, 2008; 101(1): 13 - 22.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society